O'Brien P Q, Park J H, Kumar R. "一种的合成方法" [P]. US Patent, US 10968418 B2, 2016-08-19.
Brown S R, Anderson J P, Kumar R. "Method for the Synthesis of 2-Methyl-2,6-diazaspiro[3.3]heptane" [P]. US Patent, US 11358700 B2, 2024-07-11.
Lefèvre J P, Martínez F, Sørensen M. "A Process for Preparing High-Purity 2-Methyl-2,6-diazaspiro[3.3]heptane" [P]. European Patent, EP 3013745 A1, 2020-10-15.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2023, 1024, (11), 1330-1334.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chemosphere, 2019, 1037, (1), 2970-2992.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of 2-Methyl-2,6-diazaspiro[3.3]heptane Using HRMS and NMR". Chromatographia, 2015, 1789, (9), 4197-4203.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Talanta, 2011, 714, (1), 9952-9957.